Your browser doesn't support javascript.
loading
The Role of Dihydropyrimidine Dehydrogenase and Thymidylate Synthase Polymorphisms in Fluoropyrimidine-Based Cancer Chemotherapy in an Iranian Population.
Abbasian, Mohammad Hadi; Ansarinejad, Nafiseh; Abbasi, Bahareh; Iravani, Masoud; Ramim, Tayeb; Hamedi, Fahime; Ardekani, Ali M.
Afiliación
  • Abbasian MH; Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • Ansarinejad N; Department of Hematology and Oncology, Hazrat Rasool-e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Abbasi B; Cancer Pharmacogenetics Research Group (CPGRG), Iran University of Medical Sciences, Tehran, Iran.
  • Iravani M; Cancer Pharmacogenetics Research Group (CPGRG), Iran University of Medical Sciences, Tehran, Iran.
  • Ramim T; Department of Medical Genetic, Medical Biotechnology Ins., National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
  • Hamedi F; Tehran Gastroenterology and Hepatology Center, Tehran, Iran.
  • Ardekani AM; Department of Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Avicenna J Med Biotechnol ; 12(3): 157-164, 2020.
Article en En | MEDLINE | ID: mdl-32695278

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Avicenna J Med Biotechnol Año: 2020 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Avicenna J Med Biotechnol Año: 2020 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Irán